Curetis Signs Unyvero Distribution Deal for Greater China | GenomeWeb

NEW YORK (GenomeWeb) – Curetis announced today that it has signed a deal making Beijing Clear Biotech the exclusive distributor of its Unyvero molecular testing system in China, Hong Kong, and Taiwan.

The deal also includes the Unyvero P55 cartridge for the detection of non-viral pneumonia pathogens and drug-resistant bacteria, as well as the i60 ITI cartridge for the detection of implant and tissue infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.